CO5360641A1 - Compuestos quimicos - Google Patents

Compuestos quimicos

Info

Publication number
CO5360641A1
CO5360641A1 CO00097282A CO00097282A CO5360641A1 CO 5360641 A1 CO5360641 A1 CO 5360641A1 CO 00097282 A CO00097282 A CO 00097282A CO 00097282 A CO00097282 A CO 00097282A CO 5360641 A1 CO5360641 A1 CO 5360641A1
Authority
CO
Colombia
Prior art keywords
chemical compounds
compounds
methods
farnesylation
fptase
Prior art date
Application number
CO00097282A
Other languages
English (en)
Inventor
Francis Thomas Boyle
Michael James Wardelworth
Matusiak Zbignieew
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5360641A1 publication Critical patent/CO5360641A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de fórmula I que inhiben la farnesilación de productos de genes a través de inhibición de la enzima transferasa de proteína farnesil (FPtase) La invención también se relaciona con métodos de fabricar los compuestos, composiciones farmacéuticas y métodos de tratamiento de enfermedades, especialmente cáncer, las cuales están mediadas a través de farnesilación.
CO00097282A 1999-12-22 2000-12-22 Compuestos quimicos CO5360641A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9930318.2A GB9930318D0 (en) 1999-12-22 1999-12-22 Novel compounds

Publications (1)

Publication Number Publication Date
CO5360641A1 true CO5360641A1 (es) 2004-01-30

Family

ID=10866834

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00097282A CO5360641A1 (es) 1999-12-22 2000-12-22 Compuestos quimicos

Country Status (27)

Country Link
US (1) US7101897B2 (es)
EP (1) EP1255733B1 (es)
JP (1) JP3742593B2 (es)
KR (1) KR20020063251A (es)
CN (2) CN1229344C (es)
AR (1) AR029460A1 (es)
AT (1) ATE316074T1 (es)
AU (1) AU776003B2 (es)
BR (1) BR0016669A (es)
CA (1) CA2387579A1 (es)
CO (1) CO5360641A1 (es)
CZ (1) CZ20022125A3 (es)
DE (1) DE60025650D1 (es)
EE (1) EE200200206A (es)
GB (1) GB9930318D0 (es)
HU (1) HUP0204135A3 (es)
IL (1) IL149871A0 (es)
IS (1) IS6358A (es)
MX (1) MXPA02005981A (es)
MY (1) MY133606A (es)
NO (1) NO20022924D0 (es)
NZ (1) NZ518341A (es)
PL (1) PL355887A1 (es)
RU (1) RU2259997C2 (es)
SK (1) SK8642002A3 (es)
WO (1) WO2001046137A1 (es)
ZA (1) ZA200202694B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
WO2006038719A1 (ja) * 2004-10-08 2006-04-13 Kotobuki Pharmaceutical Co., Ltd. ホスホン酸誘導体及び血中の高リン酸が関与する疾患の治療剤
US20110136867A1 (en) * 2006-02-02 2011-06-09 Justman Craig J Treatment of Synucleinopathies
WO2009151683A2 (en) 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
JP2012508768A (ja) 2008-11-13 2012-04-12 リンク・メディスン・コーポレーション アザキノリノン誘導体及びその使用
JP2012520884A (ja) 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物
WO2011088126A2 (en) * 2010-01-13 2011-07-21 Eiger Biopharmaceuticals, Inc. Treatment of viral infection with prenyltransferase inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
CA1281720C (en) 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
KR880006244A (ko) 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
GB8921635D0 (en) 1989-09-25 1989-11-08 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
CA2036163C (en) 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
FI96863C (fi) 1990-02-23 1996-09-10 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi
GB9107363D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US6083917A (en) 1990-04-18 2000-07-04 Board Of Regents, The University Of Texas System Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5185248A (en) 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
JPH0578360A (ja) 1991-01-31 1993-03-30 Banyu Pharmaceut Co Ltd ２−［２−（スルフアモイルアルキル）ピロリジニルチオカルバペネム誘導体
GB9107342D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
FI101226B (fi) 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-£2-(karbonyyli)pyrrolidin-4- yylitio|-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyyliha ppojohdannaisten valmistamiseksi
JPH04368386A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd １−メチルカルバペネム−３−カルボン酸の製造法
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
DE69204007T2 (de) 1991-10-11 1996-03-21 Squibb & Sons Inc Verwendung von Farnesyl-Protein Transferaseinhibitoren zur Herstellung eines Arzneimittels zur Blockierung von durch Ras-Oncogenen hervorgerufenen neoplastischen Transformationen von Zellen.
JPH05239058A (ja) 1991-12-17 1993-09-17 Fujisawa Pharmaceut Co Ltd ３−ピロリジニルチオ−１−アザビシクロ［３．２．０ヘプト−２−エン−２−カルボン酸化合物
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
FI103046B (fi) 1992-03-11 1999-04-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemij ohdannaisten valmistamiseksi
CA2091309A1 (en) 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
GB9304156D0 (en) 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2117899A1 (en) 1992-04-13 1993-10-28 Masayoshi Murata Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
EP0581501B1 (en) 1992-07-21 1998-09-09 Zeneca Limited Antibiotic carbapenem compounds
EP0581502B1 (en) 1992-07-21 1998-10-21 Zeneca Limited Antibiotic carbapenem compounds
CA2099818A1 (en) 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
EP0590885B1 (en) 1992-09-28 2000-03-15 Zeneca Limited Antibiotic carbapenem compounds
CA2106330A1 (en) 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
US5736539A (en) 1993-06-18 1998-04-07 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2534823B2 (ja) 1993-07-07 1996-09-18 日本電気株式会社 印刷装置
US5468733A (en) 1993-09-30 1995-11-21 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JPH09504277A (ja) 1993-09-30 1997-04-28 メルク エンド カンパニー インコーポレーテッド ファルネシル−タンパク質トランスフェラーゼの阻害剤
CA2155448A1 (en) 1994-08-11 1996-02-12 Katerina Leftheris Inhibitors of farnesyl protein transferase
US5571835A (en) 1994-09-29 1996-11-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2216564A1 (en) 1995-03-29 1996-10-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
ATE236154T1 (de) 1995-07-31 2003-04-15 Shionogi & Co Pyrrolydin-derivate mit einer phospholipase a2 inhibierenden wirkung
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
JPH1050029A (ja) 1996-05-28 1998-02-20 Nobuyuki Higuchi 情報記憶装置
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
EP0975603A1 (en) 1997-01-29 2000-02-02 Zeneca Limited Inhibitors of farnesyl protein transferase
ES2387211T3 (es) 1997-05-07 2012-09-18 University Of Pittsburgh Inhibidores de proteínas isoprenil transferass
AU2435199A (en) 1998-02-10 1999-08-30 Astrazeneca Uk Limited Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
RU2259997C2 (ru) 2005-09-10
WO2001046137A1 (en) 2001-06-28
US20030083348A1 (en) 2003-05-01
PL355887A1 (en) 2004-05-31
CN1229344C (zh) 2005-11-30
BR0016669A (pt) 2002-10-08
HUP0204135A2 (hu) 2003-03-28
US7101897B2 (en) 2006-09-05
EE200200206A (et) 2003-04-15
NZ518341A (en) 2004-01-30
IL149871A0 (en) 2002-11-10
SK8642002A3 (en) 2002-12-03
AU776003B2 (en) 2004-08-19
NO20022924L (no) 2002-06-18
CN1411442A (zh) 2003-04-16
MY133606A (en) 2007-11-30
GB9930318D0 (en) 2000-02-09
JP3742593B2 (ja) 2006-02-08
AR029460A1 (es) 2003-07-02
NO20022924D0 (no) 2002-06-18
IS6358A (is) 2002-04-23
CN1680313A (zh) 2005-10-12
MXPA02005981A (es) 2005-07-01
HUP0204135A3 (en) 2005-03-29
EP1255733A1 (en) 2002-11-13
ZA200202694B (en) 2003-12-31
JP2003518091A (ja) 2003-06-03
CA2387579A1 (en) 2001-06-28
CZ20022125A3 (cs) 2002-09-11
EP1255733B1 (en) 2006-01-18
KR20020063251A (ko) 2002-08-01
RU2002119405A (ru) 2004-01-10
ATE316074T1 (de) 2006-02-15
DE60025650D1 (de) 2006-04-06
AU2201301A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
DE69905476T2 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
BR9908280A (pt) Inibidores de enzimas de fosfolipase
WO2001056552A3 (en) Farnesyl protein transferase inhibitors for treating breast cancer
ES2130452T3 (es) Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica.
BR0104424A (pt) Composições de pirazol úteis como inibidores de erk
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
BRPI0417708A (pt) derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases
NO20055863L (no) W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
BR9712831A (pt) Inibidores tricìclicos de farnesil proteìna transferase
PT966465E (pt) Inibidores do enzima imfdh
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
AU2002218311A1 (en) Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
ATE438618T1 (de) Inhibitoren von humanem adam-10
ATE282607T1 (de) Tryptase-inhibitoren
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
CO5360641A1 (es) Compuestos quimicos
DK1105114T3 (da) Nimesulidholdige topiske farmaceutiske sammensætninger
BR0309386A (pt) Inibidores de metaloproteinases de triaril-óxi-arilóxi-pirimidina-2,4,6-triona
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.
HN1998000091A (es) Inhibidores de la farnesil transferasa tratamiento del cancer.
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
NO983511D0 (no) Difenylstilbener som pro-legemidler for COX-2-inhibitorer
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.

Legal Events

Date Code Title Description
FC Application refused